Search Results - "Leohr, Jennifer K"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry

    Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry by Bui, Hai H., Leohr, Jennifer K., Kuo, Ming-Shang

    Published in Analytical biochemistry (15-04-2012)
    “…We have developed an analytical method used to quantify sphingolipids, including deoxysphingoid bases, in lipid extracts prepared from human plasma. In total,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection Sites

    Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection Sites by Leohr, Jennifer K., Dellva, Mary Anne, LaBell, Elizabeth, Coutant, David E., Linnebjerg, Helle

    Published in Clinical therapeutics (01-06-2022)
    “…Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1

    Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1 by Leohr, Jennifer K., Luffer‐Atlas, Debra, Luo, M. Jane, DeBrota, David J., Green, Colin, Mabry, Thomas E., Suico, Jeffrey G.

    Published in Journal of clinical pharmacology (01-04-2018)
    “…The safety, pharmacokinetic, and pharmacodynamic effects of LY2584702, a selective inhibitor for p70 S6 serine/threonine protein kinase‐1, were evaluated in…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats

    Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats by Estridge, Thomas B, Dey, Asim B, Reidy, Charles, Yu, Xiaohong, Zhang, Yuke, Hartley, Maryalice, Milligan, Paul L, Jin, Najia, Kowala, Mark C, Leohr, Jennifer K, Fretland, Adrian J, Mabry, Thomas E, Luffer-Atlas, Debra, Luo, M Jane

    “…LY2584702 is an inhibitor of p70 S6 kinase-1 previously developed for the treatment of cancer. In two phase 1 trials in oncology patients, significant…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  5. 5
    96 - Ultra Rapid Lispro (URLi) Lowers Postprandial Glucose (PPG) and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs

    96 - Ultra Rapid Lispro (URLi) Lowers Postprandial Glucose (PPG) and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs by Heise, Tim, Linnebjerg, Helle, Cao, Dachuang, Coutant, David E., Labell, Elizabeth S., Reddy, Shobha R., Bowerman, Sabina, Zijlstra, Eric, Kapitza, Christoph, Bue-Valleskey, Juliana M., Zhang, Qianyi, Leohr, Jennifer K.

    Published in Canadian journal of diabetes (01-10-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Abstract A86: A phase 1 study of LY2523355, an Eg5 inhibitor, administered on Days 1, 2, and 3 with or without pegfilgrastim in patients with advanced malignancy (NCT01214629)

    Abstract A86: A phase 1 study of LY2523355, an Eg5 inhibitor, administered on Days 1, 2, and 3 with or without pegfilgrastim in patients with advanced malignancy (NCT01214629) by Verschraegen, Claire, Cohen, Roger B., Olszanski, Anthony J., Shaheen, Montaser, Nishida, Yuko, Bauman, Julie, Li, Lily, Brandt, John T., Nasir, Aejaz, Hynes, Scott M., Leohr, Jennifer K., McGlothlin, Anna, Westin, Eric H.

    Published in Molecular cancer therapeutics (12-11-2011)
    “…Abstract Background: LY2523355 is a potent allosteric inhibitor of the motor protein Eg5 which selectively inhibits bipolar mitotic spindle formation. The…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Expression of a Mutated Form of Hepatic Nuclear Factor-4[Alpha]1 Attenuates Glucose-Stimulated Insulin Secretion in [Beta]TC6, F7 Cells

    Expression of a Mutated Form of Hepatic Nuclear Factor-4[Alpha]1 Attenuates Glucose-Stimulated Insulin Secretion in [Beta]TC6, F7 Cells by GOLD, GERALD, LEOHR, JENNIFER K, VALASEK, KATHY, REIFEL-MILLER, ANNE R, HSU, ALEX, SHI, YUGUANG, FRASER, JAMES D

    Published in Diabetes (New York, N.Y.) (01-05-1999)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: